Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CA125”

68 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 68 results

Not applicableStudy completedNCT00043472
What this trial is testing

Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk

Who this might be right for
Breast CancerOvarian Cancer
National Cancer Institute (NCI) 40
Large-scale testing (Phase 3)Ended earlyNCT00050375
What this trial is testing

Clinical Trial for Ovarian Cancer (OvaRex®)

Who this might be right for
Ovarian Cancer
Unither Pharmaceuticals 354
Not applicableUnknownNCT02247323
What this trial is testing

Ovarian Malignancy Incidence in Moderate Risk Women With Low CA 125

Who this might be right for
Ovarian Cancer
Beni-Suef University 200
Post-approval studies (Phase 4)Study completedNCT02008110
What this trial is testing

Carbohydrate Antigen 125-guided Therapy in Heart Failure

Who this might be right for
Heart Failure
Fundación para la Investigación del Hospital Clínico de Valencia 360
Not applicableStudy completedNCT03498924
What this trial is testing

Identification and Characterization of Endometrial Cancer With Specific Tumor Markers in Serum and Endometrial Tissue

Who this might be right for
Endometrial Neoplasm Malignant
Fundación Investigación Sanitaria en León 80
Not applicableUnknownNCT03982914
What this trial is testing

The Use of HE4 With Simple Ultrasound Rules to Predict Malignancy in a Pelvic Mass

Who this might be right for
Pelvic Mass
The University of Hong Kong 814
Not applicableStudy completedNCT02091557
What this trial is testing

CA 125 and VAS Pain Score Changes to Diagnose Endometriosis

Who this might be right for
Pelvic PainEndometriosis
University Magna Graecia 118
Testing effectiveness (Phase 2)Ended earlyNCT00926107
What this trial is testing

Study of the mTOR Inhibitor Temsirolimus (CCI-779) to Treat Ovarian Cancer With CA125 Only Relapse

Who this might be right for
Ovarian Cancer
Hellenic Cooperative Oncology Group 9
Testing effectiveness (Phase 2)Looking for participantsNCT07022535
What this trial is testing

Personalised Timing of Interval Debulking Surgery in Advanced Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer
The University of Hong Kong 18
Early research (Phase 1)Looking for participantsNCT06469281
What this trial is testing

Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers

Who this might be right for
Epithelial Ovarian CancerPrimary Peritoneal CarcinomaFallopian Tube Cancer
Regeneron Pharmaceuticals 90
Not applicableStudy completedNCT00987649
What this trial is testing

Ovarian Cancer Risk Estimation in Patients With Pelvic Mass

Who this might be right for
Adnexal MassOvarian Cancer
Fujirebio Diagnostics, Inc. 512
Not applicableStudy completedNCT01924117
What this trial is testing

Genotypification and Predisposing Factors in Human Papilloma Virus Infection

Who this might be right for
Intraepithelial Neoplasia
Materno-Perinatal Hospital of the State of Mexico 129
Not applicableStudy completedNCT03004391
What this trial is testing

Development of a Decision Aid to Facilitate Ovarian Cancer Patient's Choices Regarding Biomarker CA125

Who this might be right for
Ovarian Cancer
Vejle Hospital 25
Not applicableNot Yet RecruitingNCT07153705
What this trial is testing

OCS Products Based on Exosome Technology Were Applied in the Recurrence Monitoring Study After the Initial Treatment of Baseline CA125-negative Ovarian Cancer

Who this might be right for
Ovarian Cancer
Beihua Kong 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT04938583
What this trial is testing

Oregovomab in Combination With Bevacizumab Plus Chemo in BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer

Who this might be right for
Ovarian Cancer by FIGO StageOvarian Cancer Stage IIIOvarian Cancer Stage IV
CanariaBio Inc. 54
Not applicableStudy completedNCT02595281
What this trial is testing

HE4 as a Relapse Biomarker in Ovarian Cancers

Who this might be right for
Ovarian Carcinoma
Institut de Cancérologie de Lorraine 90
Testing effectiveness (Phase 2)Looking for participantsNCT07617753
What this trial is testing

Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16) pt2

Who this might be right for
Epithelial Ovarian CancerPrimary Peritoneal CarcinomaFallopian Tube Carcinoma+1 more
Beijing Biotech 36
Not applicableWithdrawnNCT00080639
What this trial is testing

CA-125 in Screening Patients at High Risk for Ovarian Cancer

Who this might be right for
Ovarian Cancer
University of Alabama at Birmingham
Not applicableStudy completedNCT00086567
What this trial is testing

Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers

Who this might be right for
Fallopian Tube CancerPeritoneal NeoplasmsEpithelial Ovarian Cancer
National Cancer Institute (NCI) 119
Large-scale testing (Phase 3)UnknownNCT04835064
What this trial is testing

Pancreatic Cancer With Elevated Serum CA125 Were Compared With Those Who Did Not Receive Neoadjuvant Chemotherapy.

Who this might be right for
Pancreatic Adenocarcinoma
Fudan University 600
Load More Results